Protego Biopharma
PrivateLast Round
Series B
Dec 1, 2025
Total Funding Raised
$181M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Protego Biopharma is a biotechnology company that develops a small molecule therapeutics platform aimed at reprogramming protein folding to treat systemic amyloid diseases and other protein misfolding disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protego Biopharma Comparables
Compare Protego Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vicinitas Therapeutics | 81% | |
| Congruence Therapeutics | 80% | |
| Gain Therapeutics Inc | 78% | |
Protego Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2025 | ||||
| Series A | Nov 17, 2021 |
Key People
Founding team and executive leadership
Protego Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Seed, Series A |
| Omega Funds | Series B |
| Forbion | Series B |
| Digitalis Ventures | Series B |
| Vida Ventures | Series B, Series A |
| MPM BioImpact | Series B |
| Droia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Lead AL amyloidosis program advances to Phase III registrational trial.
- Apr 27, 2026
Open roles increased to 12, representing 50% of headcount.
Protego Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Protego Biopharma's valuation, stock price, and market status.